Canada — Canada s Drug Agency
Tracked across 2 events · 13 articles · First seen Jul 06, 2026 · Last active Jul 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Issued updated recommendation to fund lecanemab for early-stage Alzheimer's, reversing earlier decision.
Jul 16, 2026 · 7 articles
Business
Impact: CDA-AMC issued a positive reimbursement recommendation for ALYFTREK in December 2025, which preceded the LOI.
Jul 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Canada — Canada s Drug Agency live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard